Wound Closure Techniques
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
A Comparison of Skin Closure Techniques after Primary Cesarean Delivery. Traci N. Gray, M.D. and Peter F. Schnatz, D.O.
A prospective, observer blinded, randomized, and controlled trial comparing Dermabond closure technique to suture closure of skin.
Study Participants: All women age 18years or older who provide informed consent prior to primary Cesarean delivery at Hartford Hospital. Women with vertical skin incisions and or who are febrile preop or intraop will be excluded.
Methods: Qualified participants will then be randomized to skin closure with either Dermabond or suture. Surgeon preference will dictate usage of 4-0 monocryl or 4-0 vicryl for skin closure for patients randomized to the suture arm.
- The circulating nurse will time all skin closures.
- The surgeon will complete a 3 question survey immediately postop.
- At the 6 week post partum visit, patients and the health care professional will complete a brief query regarding cosmetic appeal and pain. A disposable camera will be supplied to each provider office and a photo will be taken of the incision.
- All photos will be evaluated for cosmesis by physicians who will be blinded to the methods of skin closure.
Primary Outcomes: To compare the time needed to close skin. To compare cosmetic outcome after healing
Secondary Outcomes: Patient Pain scores. Provider and patient satisfaction. Responses to questions.
| Condition | Intervention |
|---|---|
|
Wounds, Closure |
Device: Dermabond |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | A Comparison of Skin Closure Techniques After Primary Cesarean Delivery |
- Time needed to close skin.
- Cosmetic outcome after healing
- Patient Pain scores.
- Provider and patient satisfaction.
- Responses to questions.
| Estimated Enrollment: | 120 |
| Study Start Date: | November 2005 |
| Estimated Study Completion Date: | December 2008 |
Show Detailed Description
Eligibility| Ages Eligible for Study: | 18 Years to 60 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Patients undergoing a primary Cesarean Delivery
- Eighteen years of age or older
Exclusion Criteria:
- Allergy to Dermabond
- Fever pre or intra operatively
- The need for a vertical skin incision
Contacts and Locations| United States, Connecticut | |
| Hartford Hospital | Recruiting |
| Hartford, Connecticut, United States, 06102 | |
| Contact: Traci Gray, M.D. 860-825-4623 | |
| Principal Investigator: | Peter F. Schnatz, D.O. | Hartford Hospital |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00282633 History of Changes |
| Other Study ID Numbers: | SCHN001820HU |
| Study First Received: | January 25, 2006 |
| Last Updated: | October 30, 2007 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Hartford Hospital:
|
Cesarean Delivery Wound closure Suture Alternative therapy Surgery |
ClinicalTrials.gov processed this record on June 13, 2013